Skip to main content
. 2022 Mar 21;15(1):59–69. doi: 10.4103/ijoy.ijoy_160_21

Table 3.

Comparison between control group and intervention group parameters at day 14

Parameters Control group (n=38) Intervention group (n=34) P (Cohen’s d effect size)
IOP-r (mm hg) 16 (13.3-17.85) 15.85 (13.93-17.4) 0.649
Δt1-t2 0 (−2.0-+0.50) 0 (−2.0-0) 0.677 (0.1406)
IOP-l (mm hg) 16.22±3.7 15.36±2.62 0.261
Δt1-t2 0 (−2.0-+1.0) −1.00 (−2.0-0) 0.258 (0.2760)
GQL-15 28.5 (21-42.25) 29.5 (19-42.25) 0.898
Average BREF 61.33±13.77 61.51±12.64 0.963
Cortisol 297.9 (194.3-366.4) 225.7 (186.9-414.5) 0.872
Beta endorphin 136.5 (73.09-402) 178.1 (47.73-355.8) 0.956
HR (bpm) 78.08±12.85 77.59±10.33 0.859
SBP (mm hg) 120.9±11.76 130±15.59 0.006*
DBP (mm hg) 78.5 (66.5-84) 79 (74-85) 0.251
FBG (mg/dl) 96.27 (89.09-106) 94.84 (84.7-112.1) 0.538
Weight (kg) 60.4 (55.4-70.45) 67.85 (59.65-82.65) 0.091
BMI (kg/sqm) 25.12 (22.81-27.07) 27.03 (23.26-29.62) 0.123

*P value found <0.05. Unpaired t-test results are presented as mean±SD and Mann-Whitney U-test results are presented as median (Q1-Q3). Δt represents gain score i.e., the change in the value in comparison to the baseline value at day 1. SD=Standard deviation, IOP=Intraocular pressure, IOP-r=IOP of right, IOP-l=IOP of left, GQL-15=Glaucoma quality of life-15, HR=Heart rate, BP=Blood pressure, SBP=Systolic BP, DBP=Diastolic BP, BMI=Body mass index, FBG=Fasting plasma glucose, Q1=First quartile, Q3=Third quartile